Stifel raised the firm’s price target on Patterson-UTI (PTEN) to $13 from $12 and keeps a Buy rating on the shares following what the firm calls “solid” Q1 results and a better-than-expected Q2 outlook. Geopolitical tensions and potential headwinds from softening commodity prices remain a headwind, but Patterson-UTI’s “high-quality assets appear well positioned,” the analyst tells investors in a post-earnings note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTEN:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue